Hate needles? Lilly’s weightloss pill could get FDA approval next year, CEO says

Jan 21, 2025

Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce. Read More

To add this website to your home screen:

1. Tap

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.